Projekt

SAKK 06/19 Intravesical recombinant BCG followed by perioperative chemo-immunotherapy for patients with muscleinvasive bladder cancer (MIBC).A multicenter, single-arm phase II trial

Laufend - Rekrutierung – laufend · 2022 bis 2030